ALYI yields 51282.05% · PFE yields 6.13%● Live data
📍 ALYI pulled ahead of the other in Year 1
Combined, ALYI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALYI + PFE for your $10,000?
Alternet Systems, Inc., through its subsidiaries, focuses on providing digital payments and data analytics, micro segmentation, and marketing intelligence services for the mass consumer goods, payments, financial services, and telecommunications sectors. It offers financial services software, including biometric authentication, multichannel payment solutions, electronic point of sale modernization, payment processing, and data analytics tools, as well as NFC point of sale solutions for the mobile financial industry. The company is also involved in the modernization of the electronics point of sale legacy infrastructure expanding the useful life of the electronic point of sale; and including new payment functions in the terminals, such as bill payment, electronic top-up, and native payments with digital currency at the point of sale. In addition, it provides data analytics tools and services for the telecommunications and financial services industries. Further, the company produces and sells electric motorcycles. The company holds a partnership with iQSTEL, Inc. to codevelop two-way device communication solutions specific to the EV operating environment. Alternet Systems, Inc. is headquartered in Miami, Florida.
Full ALYI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.